Morris Arlene: insider trades.
Morris Arlene reported 4 non-derivative transactions on 3 SEC ownership filings in Q3 2026: 0 open-market purchases and 2 sales ($1.7M), across 1 company.
- Transactions
- 4
- Purchases (P)
- 0
- Sales (S)
- 2
- Companies
- 1
- Name as filed
- Morris Arlene
Companies
| Company | Relationship | Transactions |
|---|---|---|
| Cogent Biosciences, Inc. (COGT) | Director | 4 |
Transactions
| Date | Company | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| 2026-08-27 | Cogent Biosciences, Inc. | M | 41,927 | $5.64 | 41,927 | Form 4 |
| 2026-08-27 | Cogent Biosciences, Inc. | S | 3,161 | $37.54 | 0 | Form 4 |
| 2026-08-27 | Cogent Biosciences, Inc. | S | 42,349 | $37.09 | 3,161 | Form 4 |
| 2026-08-27 | Cogent Biosciences, Inc. | M | 3,583 | $2.52 | 45,510 | Form 4 |
Questions
What stock did Morris Arlene buy or sell?
Morris Arlene reported 4 non-derivative transactions on 3 SEC ownership filings in Q3 2026: 0 open-market purchases and 2 sales ($1.7M), across 1 company.
Is Morris Arlene the same person as other filers with this name?
This page covers SEC CIK 1362520 only. The SEC assigns each reporting owner a CIK, and people with the same name have different CIKs.
Source: SEC Insider Transactions Data Sets, Q3 2026. Reported as filed; we do not assess intent, performance or compliance. All filings for this CIK on SEC.gov.
Plain-text version for agents and LLMs: /insiders/morris-arlene-1362520.md
Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.